Chief Medical Officer, Mark Berger, MD, Discusses Collaboration with Large Network of Community-Based Oncology Practices

Genprex’s Chief Medical Officer discusses the Company’s collaboration with a large network of community-based oncology practices to open additional sites for the Acclaim-3 clinical trial in SCLC